Edward Livant

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Jared M. Baeten, Thesla Palanee‐Phillips, Elizabeth R. Brown et al. · Obstetrical & Gynecological Survey · 2016 · 373 citations

Medicine, Infectious Diseases, Preventive Medicine +15

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

Ian McGowan, Kailazarid Gomez, Karen Bruder et al. · AIDS · 2011 · 125 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +15

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi et al. · The Lancet HIV · 2021 · 111 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +16

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

Gonasagrie Nair, Connie Celum, Daniel Szydlo et al. · The Lancet HIV · 2023 · 60 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17

Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations

Catherine A. Koss, Peter Bacchetti, Sharon L. Hillier et al. · AIDS Research and Human Retroviruses · 2017 · 57 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17